Project Number GC-2012584 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2015 View Full Project Details for Selective HDAC2 Inhibitors for the Treatment of Cognitive Deficits in Alzheimer's Disease - Year 2 Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) q. Epigenetic Regulators Researcher and Organization Principal Investigator Jefson, Martin Principal Investigator First Name MARTIN R Principal Investigator Last Name JEFSON Awardee Organization Rodin Therapeutics Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement Preclinical RFP FY Overall Cost $75,683 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States
